Table 1.
Comparison of α3β1, CD151, and CD9 expression levels on various cell types
| Cell line designation | Tissue derivation | Expressiona
|
||
|---|---|---|---|---|
| α3 | CD151 | CD9 | ||
| Nalm-6 | B cell derived | − | − | +++ |
| OCI-Ly8 | B cell derived | − | − | ++ |
| Molt-4 | T cell derived | − | + | + |
| K562 | Erythroleukemia | − | ++ | − |
| Jurkat | T cell derived | + | + | + |
| Peer | T cell derived | + | ++ | ND |
| RD | Rhabdomyosarcoma | + | ++ | + |
| NT-2 | Embryonic carcinoma | + | + | + |
| SSC25 | Squamous cell carcinoma | ++ | ++ | − |
| HT1080 | Fibrosarcoma | +++ | +++ | − |
| CAKI-1 | Kidney carcinoma | +++ | +++ | − |
| MDA-MB-231 | Breast carcinoma | +++ | +++ | − |
| A431 | Epidermoid carcinoma | +++ | +++ | ++ |
a
Cell surface expression levels of α3, CD151, and CD9 were determined by flow cytometry, as described in MATERIALS AND METHODS. Specific MFI values were 0–2 (−), 3–20 (+), 21–100 (++), or >101 (+++).